Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin M Goode

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Heart (British Cardiac Society)|September 16, 2011
Limited role for ivabradine in the treatment of chronic heart failureDamien Cullington, Kevin M Goode, John G F Cleland, et al.
Clinical Chemistry and Laboratory Medicine|January 11, 2014
The in vitro stability of novel cardiovascular and sepsis biomarkers at ambient temperatureKevin M Goode, Rachel Nicholls, Pierpaolo Pellicori, et al.
JACC. Heart Failure|June 23, 2014
Is heart rate important for patients with heart failure in atrial fibrillation?Damien Cullington, Kevin M Goode, Jufen Zhang, et al.
European Journal of Heart Failure|January 31, 2009
The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunctionMilos Kubánek, Kevin M Goode, Vera Lánská, et al.
European Journal of Heart Failure|November 21, 2009
Red cell distribution width: an inexpensive and powerful prognostic marker in heart failureYahya Al-Najjar, Kevin M Goode, Jufen Zhang, et al.
International Journal of Cardiology|July 6, 2011
Identifying patients at risk of death or hospitalisation due to worsening heart failure using decision tree analysis: evidence from the Trans-European Network-Home-Care Management System (TEN-HMS) studyJufen Zhang, Kevin M Goode, Alan Rigby, et al.
International Journal of Cardiology|March 7, 2016
Regional circulatory distribution of novel cardiac bio-markers and their relationships with haemodynamic measurementsPierpaolo Pellicori, Kevin M Goode, Rachel Nicholls, et al.
European Journal of Heart Failure|April 17, 2012
Relationship between plasma concentrations of N-terminal pro brain natriuretic peptide and the characteristics and outcome of patients with a clinical diagnosis of diastolic heart failure: a report from the PEP-CHF studyJohn G F Cleland, Jacqueline Taylor, Nick Freemantle, et al.
European Journal of Heart Failure|November 17, 2007
Screening for left ventricular systolic dysfunction in high-risk patients in primary-care: a cost-benefit analysisKevin M Goode, Andrew L Clark, Janet A Bristow, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 17, 2017
Prevalence, predictors, and prognostic implications of PR interval prolongation in patients with heart failureTheodora Nikolaidou, Pierpaolo Pellicori, Jufen Zhang, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Heart (British Cardiac Society)|September 16, 2011
Limited role for ivabradine in the treatment of chronic heart failureDamien Cullington, Kevin M Goode, John G F Cleland, et al.
Clinical Chemistry and Laboratory Medicine|January 11, 2014
The in vitro stability of novel cardiovascular and sepsis biomarkers at ambient temperatureKevin M Goode, Rachel Nicholls, Pierpaolo Pellicori, et al.
JACC. Heart Failure|June 23, 2014
Is heart rate important for patients with heart failure in atrial fibrillation?Damien Cullington, Kevin M Goode, Jufen Zhang, et al.
European Journal of Heart Failure|January 31, 2009
The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunctionMilos Kubánek, Kevin M Goode, Vera Lánská, et al.
European Journal of Heart Failure|November 21, 2009
Red cell distribution width: an inexpensive and powerful prognostic marker in heart failureYahya Al-Najjar, Kevin M Goode, Jufen Zhang, et al.
International Journal of Cardiology|July 6, 2011
Identifying patients at risk of death or hospitalisation due to worsening heart failure using decision tree analysis: evidence from the Trans-European Network-Home-Care Management System (TEN-HMS) studyJufen Zhang, Kevin M Goode, Alan Rigby, et al.
International Journal of Cardiology|March 7, 2016
Regional circulatory distribution of novel cardiac bio-markers and their relationships with haemodynamic measurementsPierpaolo Pellicori, Kevin M Goode, Rachel Nicholls, et al.
European Journal of Heart Failure|April 17, 2012
Relationship between plasma concentrations of N-terminal pro brain natriuretic peptide and the characteristics and outcome of patients with a clinical diagnosis of diastolic heart failure: a report from the PEP-CHF studyJohn G F Cleland, Jacqueline Taylor, Nick Freemantle, et al.
European Journal of Heart Failure|November 17, 2007
Screening for left ventricular systolic dysfunction in high-risk patients in primary-care: a cost-benefit analysisKevin M Goode, Andrew L Clark, Janet A Bristow, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 17, 2017
Prevalence, predictors, and prognostic implications of PR interval prolongation in patients with heart failureTheodora Nikolaidou, Pierpaolo Pellicori, Jufen Zhang, et al.
Pageof 3